Published in Arthritis Res Ther on November 30, 2004
Bacterial virulence in the moonlight: multitasking bacterial moonlighting proteins are virulence determinants in infectious disease. Infect Immun (2011) 1.99
Immunization with an immunodominant self-peptide derived from glucose-6-phosphate isomerase induces arthritis in DBA/1 mice. Arthritis Res Ther (2009) 0.84
S100A9 is not essential for disease expression in an acute (K/BxN) or chronic (CIA) model of inflammatory arthritis. Scand J Rheumatol (2009) 0.83
A complicated liaison: IL-33 and IL-33R in arthritis pathogenesis. Arthritis Res Ther (2013) 0.76
Association of the polymorphisms of TRAF1 (rs10818488) and TNFAIP3 (rs2230926) with rheumatoid arthritis and systemic lupus erythematosus and their relationship to disease activity among Egyptian patients. Cent Eur J Immunol (2016) 0.75
Quantification of arthritic bone degradation by analysis of 3D micro-computed tomography data. Sci Rep (2017) 0.75
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med (2004) 14.53
The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum (1987) 14.21
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet (1994) 7.04
Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol Med (1956) 6.65
Organ-specific disease provoked by systemic autoimmunity. Cell (1996) 6.44
Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature (1988) 6.18
Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science (2002) 5.82
The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol (1973) 5.64
From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity (1999) 5.38
Arthritis critically dependent on innate immune system players. Immunity (2002) 5.31
Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science (1999) 4.97
Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med (2003) 4.67
Moonlighting proteins. Trends Biochem Sci (1999) 4.53
Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol (2001) 4.39
Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol (2002) 4.37
Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature (2003) 4.22
How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum (1990) 3.78
Serum transfer of collagen-induced arthritis in mice. J Exp Med (1983) 3.74
Primary biliary cirrhosis. N Engl J Med (1996) 3.51
Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease. Nat Immunol (2001) 3.39
The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum. Proc Natl Acad Sci U S A (2001) 3.39
Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum (2004) 3.38
Predominantly T-cell infiltrate in rheumatoid synovial membranes. N Engl J Med (1975) 3.35
Effects of oral administration of type II collagen on rheumatoid arthritis. Science (1993) 3.32
Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med (1998) 3.20
How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol (2002) 3.20
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res (2000) 3.03
Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J Exp Med (2002) 2.98
Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity. Nature (1983) 2.71
Induction of arthritis with monoclonal antibodies to collagen. J Immunol (1992) 2.64
Tumor cell autocrine motility factor. Proc Natl Acad Sci U S A (1986) 2.28
Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev (1990) 2.24
Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res (2001) 2.18
The neurotrophic factor neuroleukin is 90% homologous with phosphohexose isomerase. Nature (1988) 2.16
Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J Exp Med (1995) 2.02
Genetic influences on the end-stage effector phase of arthritis. J Exp Med (2001) 1.99
Tolerance and autoimmunity. N Engl J Med (2001) 1.96
Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum (1989) 1.95
Arthritogenic monoclonal antibodies from K/BxN mice. J Exp Med (2002) 1.94
Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol (2003) 1.81
Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice. J Immunol (2004) 1.77
Electrical charge of the antigen determines intraarticular antigen handling and chronicity of arthritis in mice. J Clin Invest (1984) 1.75
Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc Natl Acad Sci U S A (1989) 1.72
Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons. Science (1986) 1.72
The role of FcgammaR signaling in the K/B x N serum transfer model of arthritis. J Immunol (2002) 1.70
How important are T cells in chronic rheumatoid synovitis?: II. T cell-independent mechanisms from beginning to end. Arthritis Rheum (2002) 1.69
Dynamic visualization of a joint-specific autoimmune response through positron emission tomography. Nat Immunol (2002) 1.68
Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med (1999) 1.61
Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics. Crit Rev Immunol (2003) 1.58
The autoantibody repertoire: searching for order. Nat Rev Immunol (2003) 1.57
Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci U S A (2002) 1.55
Major histocompatibility complex-directed susceptibility to rheumatoid arthritis. Adv Immunol (1998) 1.52
Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression. Arthritis Rheum (1996) 1.52
Arthritis in DBA/1 mice induced with passively transferred type II collagen immune serum. Immunohistopathology and serum levels of anti-type II collagen auto-antibodies. Scand J Immunol (1990) 1.51
Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis. Immunol Rev (2001) 1.50
The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targets. Curr Opin Rheumatol (2003) 1.49
Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes. J Immunol (2004) 1.48
The molecular basis of susceptibility to rheumatoid arthritis. Adv Immunol (1994) 1.47
Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 1.46
Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthritis Rheum (1991) 1.45
Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response. Arthritis Rheum (1994) 1.44
Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. Arthritis Rheum (2003) 1.41
Rheumatoid factor revisited. Curr Opin Rheumatol (2004) 1.33
Enhanced T cell proliferative response to type II collagen and synthetic peptide CII (255-274) in patients with rheumatoid arthritis. Arthritis Rheum (1999) 1.29
Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res (2002) 1.22
Despite ubiquitous autoantigen expression, arthritogenic autoantibody response initiates in the local lymph node. Proc Natl Acad Sci U S A (2002) 1.21
Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats. Clin Exp Immunol (1998) 1.21
Massive thymic deletion results in systemic autoimmunity through elimination of CD4+ CD25+ T regulatory cells. J Exp Med (2004) 1.20
Collagen-induced arthritis in CD4- or CD8-deficient mice: CD8+ T cells play a role in initiation and regulate recovery phase of collagen-induced arthritis. J Immunol (1996) 1.17
The role of CD40 ligand and tumor necrosis factor alpha signaling in the transgenic K/BxN mouse model of rheumatoid arthritis. Arthritis Rheum (2000) 1.17
The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase. Blood (1996) 1.14
Passive transfer studies with type II collagen antibody in B10.D2/old and new line and C57Bl/6 normal and beige (Chediak-Higashi) strains: evidence of important roles for C5 and multiple inflammatory cell types in the development of erosive arthritis. Arthritis Rheum (1987) 1.14
T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles. Arthritis Rheum (1999) 1.11
Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial. Arthritis Rheum (1996) 1.09
Proteinase 3, Wegener's autoantigen: from gene to antigen. J Leukoc Biol (2001) 1.08
Synergy between adjuvant arthritis and collagen-induced arthritis in rats. J Exp Med (1985) 1.05
Autoantigens and immune pathways in rheumatoid arthritis. Crit Rev Immunol (2002) 1.03
Mice lacking mature T and B lymphocytes develop arthritic lesions after immunization with type II collagen. J Immunol (1999) 1.02
Genetics of rheumatoid arthritis: is there a scientific explanation for the human leukocyte antigen association? Curr Opin Rheumatol (2002) 1.01
Few human autoimmune sera detect GPI. Nat Immunol (2002) 1.00
Association of autoantibodies to glucose-6-phosphate isomerase with extraarticular complications in rheumatoid arthritis. Arthritis Rheum (2004) 0.99
Proteasome alpha-type subunit C9 is a primary target of autoantibodies in sera of patients with myositis and systemic lupus erythematosus. J Exp Med (1996) 0.98
Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8. Arthritis Res (2000) 0.96
Cell shape modulation alters glycosylation of a metastatic melanoma cell-surface antigen. Int J Cancer (1987) 0.96
Autoantibodies to GPI and creatine kinase in RA. Nat Immunol (2002) 0.96
T cell responses to human type II collagen in patients with rheumatoid arthritis and healthy controls. Arthritis Rheum (1997) 0.95
Phosphoglucose isomerase of human erythrocytes and cardiac tissue. Methods Enzymol (1975) 0.94
The genetics of rheumatoid arthritis and the need for animal models to find and understand the underlying genes. Arthritis Res (2000) 0.93
Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice. J Immunol (2004) 0.91
Monoarticular antigen-induced arthritis leads to pronounced bilateral upregulation of the expression of neurokinin 1 and bradykinin 2 receptors in dorsal root ganglion neurons of rats. Arthritis Res (2000) 0.90
Rheumatoid arthritis is more than cytokines: autoimmunity and rheumatoid arthritis. Arthritis Rheum (2001) 0.89
Induction of experimental allergic arthritis with outer surface proteins of Borrelia burgdorferi. Arthritis Rheum (1994) 0.87
Lack of efficacy of oral bovine type II collagen added to existing therapy in rheumatoid arthritis. Arthritis Rheum (1999) 0.86
Death of mouse embryos that lack a functional gene for glucose phosphate isomerase. Genet Res (1991) 0.86
Anti-type II collagen antibodies in rheumatoid arthritis. The influence of HLA phenotype. Tissue Antigens (1984) 0.85
Type XI collagen-induced arthritis in the Lewis rat. Characterization of cellular and humoral immune responses to native types XI, V, and II collagen and constituent alpha-chains. J Immunol (1994) 0.85
Immunological treatment of autoimmune diseases. Adv Immunol (1998) 0.85
Antigen-specific T cells in rheumatoid arthritis. Curr Rheumatol Rep (2003) 0.84
The role of long-lived plasma cells in autoimmunity. Immunobiology (2002) 0.82
Glucose-6-phosphate isomerase is not a specific autoantigen in rheumatoid arthritis. Rheumatology (Oxford) (2003) 0.82
3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc Natl Acad Sci U S A (2005) 8.60
Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science (2009) 3.78
Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem (2002) 3.61
Protein disulfide bond formation in the cytoplasm during oxidative stress. J Biol Chem (2004) 2.44
Hydrogen sulfide protects HT22 neuronal cells from oxidative stress. Antioxid Redox Signal (2006) 1.73
The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron (2003) 1.55
Commercialized GM crops and yield. Nat Biotechnol (2009) 1.38
Distribution of the cystine/glutamate antiporter system xc- in the brain, kidney, and duodenum. J Histochem Cytochem (2006) 1.20
Amyloid as a depot for the formulation of long-acting drugs. PLoS Biol (2008) 1.17
Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease. FASEB J (2005) 1.13
Safety testing and regulation of genetically engineered foods. Biotechnol Genet Eng Rev (2004) 1.11
Loss of modifier of cell adhesion reveals a pathway leading to axonal degeneration. J Neurosci (2009) 1.06
A broadly neuroprotective derivative of curcumin. J Neurochem (2008) 1.06
Induction of a B-cell-dependent chronic arthritis with glucose-6-phosphate isomerase. Arthritis Res Ther (2005) 1.03
Increase in expression levels and resistance to sulfhydryl oxidation of peroxiredoxin isoforms in amyloid beta-resistant nerve cells. J Biol Chem (2007) 1.02
The pathological interaction between diabetes and presymptomatic Alzheimer's disease. Neurobiol Aging (2008) 1.01
Modulation of 5-lipoxygenase in proteotoxicity and Alzheimer's disease. J Neurosci (2013) 1.00
Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes. PLoS One (2011) 1.00
Specificity of resistance to oxidative stress. J Neurochem (2002) 1.00
Brain and spinal cord interaction: a dietary curcumin derivative counteracts locomotor and cognitive deficits after brain trauma. Neurorehabil Neural Repair (2011) 0.98
A novel neurotrophic drug for cognitive enhancement and Alzheimer's disease. PLoS One (2011) 0.98
Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer's disease transgenic mice. Aging Cell (2013) 0.98
Autoantibodies to GPI and creatine kinase in RA. Nat Immunol (2002) 0.96
Amyloid beta resistance in nerve cell lines is mediated by the Warburg effect. PLoS One (2011) 0.94
Re: Regulatory Toxicology and Pharmacology. Int J Occup Environ Health (2003) 0.94
Multidimensional structure-activity relationship of a protein in its aggregated states. Angew Chem Int Ed Engl (2010) 0.93
Diabetes exacerbates amyloid and neurovascular pathology in aging-accelerated mice. Aging Cell (2012) 0.91
Two views of the emperor's new clones. Nat Biotechnol (2007) 0.90
Modifier of cell adhesion regulates N-cadherin-mediated cell-cell adhesion and neurite outgrowth. J Neurosci (2005) 0.90
Presenilin-interacting proteins. Expert Rev Mol Med (2002) 0.89
A pyrazole derivative of curcumin enhances memory. Neurobiol Aging (2008) 0.88
Glutathione production is regulated via distinct pathways in stressed and non-stressed cortical neurons. Brain Res (2007) 0.88
Chemical modification of the multitarget neuroprotective compound fisetin. J Med Chem (2011) 0.88
Back to the future with phenotypic screening. ACS Chem Neurosci (2014) 0.86
A novel mechanism for the regulation of amyloid precursor protein metabolism. J Cell Biol (2002) 0.86
Suppressive effects of a pyrazole derivative of curcumin on airway inflammation and remodeling. Exp Mol Pathol (2012) 0.84
Treating Alzheimer's disease by inactivating bioactive amyloid beta peptide. Curr Alzheimer Res (2006) 0.82
Detecting bioactive amyloid beta peptide species in Alzheimer's disease. J Neurochem (2004) 0.80
Transient modulation of cytoplasmic and nuclear retinoid receptors expression in differentiating human teratocarcinoma NT2 cells. J Neurochem (2003) 0.79
Synergistic effect of retinoic acid and cytokines on the regulation of glial fibrillary acidic protein expression. J Biol Chem (2010) 0.78
'Cisgenic' as a product designation. Nat Biotechnol (2006) 0.77
An integrated approach to the characterization of cell movement. Cytometry A (2005) 0.77
Regulatory regimes for transgenic crops. Nat Biotechnol (2005) 0.76
Editorial policies on financial disclosure. Nat Neurosci (2003) 0.76
Metabolism of a potent neuroprotective hydrazide. Bioorg Med Chem (2013) 0.76
Errors in text. J R Soc Med (2008) 0.75
Characterizing width uniformity by wave propagation. Phys Rev E Stat Nonlin Soft Matter Phys (2003) 0.75
Financial benefits the real motivator behind Botox. CDS Rev (2009) 0.75
The formation of bioactive amyloid species by prion proteins in vitro and in cells. Neurosci Lett (2006) 0.75